Citing concerns that artificial intelligence will make it easier for anyone to build biological weapons, the leaders of several major AI companies—in a rare moment of unity—have penned a new letter urging U.S. lawmakers to impose tighter controls on firms that sell synthetic, made-to-order strands of DNA.